Short answer
ACADIA PHARMACEUTICALS INC (ACAD) filed an 8-K current report with the SEC on October 23, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Elizabeth H.Z. Thompson retires October 23, 2026 as Executive Vice President and Head of Research and Development.
ACADIA PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Elizabeth H.Z. Thompson retires October 23, 2026 as Executive Vice President and Head of Research and Development
- Limited consulting arrangement through December 31, 2026, preserving short-term R&D transition support
- Replacement search underway, creating leadership continuity risk for Acadia’s research and development programs
- Departure for personal reasons, with no misconduct or disagreement disclosed
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACADIA PHARMACEUTICALS INC 8-K filings
Get the next ACAD 8-K as it lands
Follow ACAD for push alerts, or ask the research agent what this filing means.